**Core Concept**
The treatment of thyroid malignancy often involves radioactive iodine therapy, which leverages the thyroid gland's ability to selectively take up iodine. This property allows for targeted destruction of thyroid cancer cells.

**Why the Correct Answer is Right**
Radioactive iodine-131 (I-131) is a potent and selective agent for thyroid cancer treatment. The thyroid gland avidly takes up iodine, and I-131's beta particles can induce DNA damage and apoptosis in thyroid cancer cells, leading to tumor shrinkage and improved outcomes. I-131's use is particularly effective for differentiated thyroid cancers, such as papillary and follicular thyroid carcinomas.

**Why Each Wrong Option is Incorrect**
**Option A:** is incorrect because it's the correct answer, so we won't discuss it.
**Option B:** 125 I is used in diagnostic procedures, such as thyroid uptake scans, but not for therapeutic purposes due to its lower energy and shorter half-life compared to I-131.
**Option C:** 99m Tc is a technetium isotope used primarily in diagnostic nuclear medicine scans, including thyroid imaging, but it is not used for therapeutic purposes.
**Option D:** 32 P is a phosphorus isotope used in some medical applications, but it is not typically used in the treatment of thyroid malignancy.

**Clinical Pearl / High-Yield Fact**
When treating thyroid malignancy with radioactive iodine, it's essential to ensure the patient has adequate hydration and is on a low-iodine diet to enhance I-131 uptake by the thyroid gland.

**✓ Correct Answer: A. 131 I**